Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Effective treatments for severe alopecia areata are still lacking.

Hydrogen peroxide's effects on wound healing in hair transplants are unclear, and it may slow healing and increase scarring.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Wigs significantly improve the well-being of people with severe hair loss.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Alopecia areata may be linked to imbalanced gut bacteria.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Low vitamin D levels are common in people with Alopecia Areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Topical nitroglycerin spray effectively prevents scalp necrosis in hair transplant patients.